Skip to main content
. Author manuscript; available in PMC: 2011 Jul 9.
Published in final edited form as: J Heart Lung Transplant. 2010 Sep 24;30(1):14–21. doi: 10.1016/j.healun.2010.06.018

Table 1.

Variables Q 1–3 (N=63) Q 4 (N=21) P-value
Demographic Information
Mean age, years (SD) 44.8 (14.1) 50.6 (12.9) 0.08
Male gender, # (%) 30 (47) 14 (67) 0.1
Diabetes mellitus, # (%) 8 (13) 7 (33) 0.04
Coronary artery disease, # (%) 1 (1.6) 0 (0) 0.6
BMI, kg/cm2 (SD) 23.7 (4.6) 24.8 (5.2) 0.4
Hypertension, # (%) 17 (27) 4 (20) 0.5
Creatinine, mg/mol (SD) 0.8 (0.2) 0.9 (0.3) 0.1
O2 requirement, L/min 2.9 (1.6) 8.0 (6.4) <0.001
FEV1, % predicted (SD) 30.4 (24.7) 43.8 (23.2) 0.04
FVC, % predicted (SD) 44.7 (14.2) 50.2 (22.0) 0.2
ICU prior to LTx, # (%) 5 (8) 14 (67) <0.001
Primary Diagnosis
COPD 25 (40%) 0 (0) 0.01
Idiopathic pulmonary fibrosis 12 (19%) 6 (29%) 0.4
Cystic Fibrosis 10 (16%) 6 (29%) 0.2
Sarcoidosis 2 (3%) 3 (14%) 0.1
Primary pulmonary hypertension 2 (3%) 2 (10%) 0.2
Other 12 (19%) 4 (19%) 0.9
Transplant/Donor Variables
Donor age, years (SD) 42.1 (15.3) 42.1 (14.3) 0.9
Donor smoking history, # (%) 27 (43.5) 12 (57.1) 0.5
Left lung ischemic time, minutes (SD) 235 (88) 275 (98) 0.08
Right lung ischemic time, minutes (SD) 194 (81) 231 (72) 0.08
Bilateral LTx, # (%) 55 (87) 18 (86) 0.9
Median wait list time, days(IQR) 133 (30–677) 24 (7–149) 0.006